PE20010712A1 - Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa - Google Patents

Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Info

Publication number
PE20010712A1
PE20010712A1 PE2000001121A PE0011212000A PE20010712A1 PE 20010712 A1 PE20010712 A1 PE 20010712A1 PE 2000001121 A PE2000001121 A PE 2000001121A PE 0011212000 A PE0011212000 A PE 0011212000A PE 20010712 A1 PE20010712 A1 PE 20010712A1
Authority
PE
Peru
Prior art keywords
water
pharmaceutical composition
gum
mucosa
cyclesonide
Prior art date
Application number
PE2000001121A
Other languages
English (en)
Inventor
Atsuhiro Nagano
Kazuya Takanashi
Yoshihisa Nishibe
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856327&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20010712(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of PE20010712A1 publication Critical patent/PE20010712A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA ACUOSA PARA SER APLICADA A LA MUCOSA NASAL QUE COMPRENDE UNA O MAS SUSTANCIAS INSOLUBLES EN AGUA Y/O DE BAJA SOLUBILIDAD EN AGUA TAL COMO CELULOSA CRISTALINA; CICLESONIDA; UN AGENTE CONTROLADOR DE LA PRESION OSMOTICA TAL COMO CLORURO DE SODIO, GLUCOSA, QUE TIENE UNA PRESION OSMOTICA DE MENOS DE 290 mOsm, SE PRESENTA EN FORMA DE PARTICULAS SOLIDAS EN UN MEDIO ACUOSO; ADEMAS COMPRENDE UNA SUSTANCIA POLIMERICA SOLUBLE EN AGUA TAL COMO ACIDO ALGINICO, PROPILENGLICOL, PECTINA, GOMA GUAR, GOMA ARABIGA, CARRAGENINA, METILCELULOSA, CARBOXIMETILCELULOSA DE SODIO, GOMA XANTANO, HIDROXIPROPILCELULOSA, HIDROXIPROPILMETILCELULOSA; UN AGENTE TENSOACTIVO TAL COMO POLISORBATO
PE2000001121A 1999-10-20 2000-10-19 Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa PE20010712A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29818599 1999-10-20

Publications (1)

Publication Number Publication Date
PE20010712A1 true PE20010712A1 (es) 2001-07-12

Family

ID=17856327

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001121A PE20010712A1 (es) 1999-10-20 2000-10-19 Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Country Status (36)

Country Link
US (1) US6767901B1 (es)
EP (1) EP1225902B1 (es)
JP (1) JP4264211B2 (es)
KR (1) KR100722209B1 (es)
CN (2) CN1379674B (es)
AR (1) AR026072A1 (es)
AT (1) ATE285779T1 (es)
AU (1) AU781895B2 (es)
BG (1) BG65818B1 (es)
BR (1) BRPI0014878B8 (es)
CA (1) CA2388322C (es)
CO (1) CO5261494A1 (es)
CZ (1) CZ297779B6 (es)
DE (1) DE60017175T2 (es)
DK (1) DK1225902T3 (es)
EA (1) EA006015B1 (es)
ES (1) ES2234681T3 (es)
HK (2) HK1050858A1 (es)
HR (1) HRP20020346B1 (es)
HU (1) HU228893B1 (es)
IL (2) IL148691A0 (es)
ME (1) ME00567B (es)
MX (1) MXPA02003974A (es)
MY (1) MY136987A (es)
NO (1) NO327444B1 (es)
NZ (1) NZ518298A (es)
PE (1) PE20010712A1 (es)
PL (1) PL199702B1 (es)
PT (1) PT1225902E (es)
RS (1) RS50310B (es)
SI (1) SI1225902T1 (es)
SK (1) SK286196B6 (es)
TR (1) TR200200841T2 (es)
TW (1) TWI225788B (es)
WO (1) WO2001028562A1 (es)
ZA (1) ZA200203077B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
BRPI0312377A8 (pt) 2002-07-02 2015-12-15 Altana Pharma Ag Suspensão aquosa estéril contendo ciclesonida
US7221586B2 (en) 2002-07-08 2007-05-22 Micron Technology, Inc. Memory utilizing oxide nanolaminates
RU2343160C2 (ru) * 2002-07-26 2009-01-10 Фмк Корпорейшн Получение микрокристаллической целлюлозы
PL373433A1 (en) * 2002-08-30 2005-08-22 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
ATE405275T1 (de) * 2002-12-12 2008-09-15 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
CA2538419C (en) * 2003-09-16 2012-07-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2005102354A1 (en) * 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
EP1796679A1 (en) * 2004-09-10 2007-06-20 Altana Pharma AG Ciclesonide and syk inhibitor combination and methods of use thereof
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
EP2265250A2 (en) * 2008-03-14 2010-12-29 Cephalon, Inc. Enhanced transmucosal composition and dosage form
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter
EP1050299A4 (en) * 1998-01-22 2007-05-02 Santen Pharmaceutical Co Ltd SUSPENSION COLLYRE OF FLUOROMETHOLONE
SE514128C2 (sv) * 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Also Published As

Publication number Publication date
BRPI0014878B1 (pt) 2015-08-11
JP2003512329A (ja) 2003-04-02
YU28002A (sh) 2004-11-25
TWI225788B (en) 2005-01-01
BG65818B1 (bg) 2010-01-29
DE60017175T2 (de) 2005-12-29
CO5261494A1 (es) 2003-03-31
BRPI0014878B8 (pt) 2021-05-25
MY136987A (en) 2008-12-31
PT1225902E (pt) 2005-05-31
ATE285779T1 (de) 2005-01-15
HU228893B1 (hu) 2013-06-28
MXPA02003974A (es) 2003-09-25
HK1149719A1 (en) 2011-10-14
HK1050858A1 (zh) 2003-07-11
IL148691A (en) 2006-12-10
US6767901B1 (en) 2004-07-27
NO327444B1 (no) 2009-06-29
NO20021898D0 (no) 2002-04-22
CN101869570A (zh) 2010-10-27
SK286196B6 (sk) 2008-05-06
BR0014878A (pt) 2002-06-11
CZ297779B6 (cs) 2007-03-28
CA2388322C (en) 2007-09-18
HUP0203339A3 (en) 2004-07-28
KR100722209B1 (ko) 2007-05-29
AU781895B2 (en) 2005-06-23
CN1379674B (zh) 2014-10-29
ME00567A (en) 2011-12-20
HUP0203339A2 (hu) 2003-02-28
EP1225902A1 (en) 2002-07-31
CN101869570B (zh) 2012-10-10
AR026072A1 (es) 2002-12-26
AU7953100A (en) 2001-04-30
NO20021898L (no) 2002-04-22
ME00567B (me) 2011-12-20
CZ20021238A3 (cs) 2002-07-17
HRP20020346B1 (en) 2011-06-30
DK1225902T3 (da) 2005-05-02
BG106512A (bg) 2002-12-29
DE60017175D1 (de) 2005-02-03
RS50310B (sr) 2009-09-08
ZA200203077B (en) 2003-02-26
NZ518298A (en) 2003-11-28
JP4264211B2 (ja) 2009-05-13
IL148691A0 (en) 2002-09-12
EP1225902B1 (en) 2004-12-29
TR200200841T2 (tr) 2002-07-22
SI1225902T1 (en) 2005-06-30
WO2001028562A1 (en) 2001-04-26
EA006015B1 (ru) 2005-08-25
CA2388322A1 (en) 2001-04-26
EA200200375A1 (ru) 2002-10-31
PL356191A1 (en) 2004-06-14
CN1379674A (zh) 2002-11-13
ES2234681T3 (es) 2005-07-01
HRP20020346A2 (en) 2004-02-29
SK6922002A3 (en) 2002-09-10
PL199702B1 (pl) 2008-10-31
KR20020059627A (ko) 2002-07-13

Similar Documents

Publication Publication Date Title
PE20010712A1 (es) Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
EE9900589A (et) Farmatseutilised kompositsioonid limaskestale kandmiseks
PE20010627A1 (es) Composiciones que tienen estabilidad mejorada
CN101360464B (zh) 泡沫基质及其制备方法
EP2919805B1 (en) Stable thermolysin hydrogel
HUP0004924A2 (hu) Ciklodextrineket tartalmazó gyógyászati készítmények
ECSP044974A (es) Formulación de suspensión oral estabilizada
CO5160288A1 (es) Composiciones liquidas que contiene una emulsion estable de un agente de particula pequena, beneficio para la piel
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR044077A1 (es) Peliculas consumibles por via oral que se disuelven rapidamente, que contienen un edulcorante
JP2013536874A (ja) 鼻腔噴霧剤
EA200600528A1 (ru) Способ получения водорастворимых дитерпенов и их применение
BR0318354A (pt) composição para tratamento de pele contendo agente clareador
DE60221227D1 (de) Xanthangummi enthaltende reepithelialisierende pharmazeutische Zubereitungen
CO2022005947A2 (es) Formulaciones de cápsulas de gelatina blanda no animales, métodos de preparación y métodos de uso de las mismas
SV1999000181A (es) Composicion farmaceutica para ser aplicada a las mucosas ref. er/cr-203.689
TH66951C3 (th) ส่วนประกอบทางเภสัชกรรมที่สำหรับใช้กับเยื่อบุ
CR6122A (es) Composicion farmaceutica para ser aplicada a las mucosas
MY124416A (en) Pharmaceutical composition for application to mucosa
AU2012200105A1 (en) Bioadhesive composition with programmed release

Legal Events

Date Code Title Description
FG Grant, registration
MK Expiration of term